Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · IEX Real-Time Price · USD
7.85
+0.10 (1.29%)
At close: Jul 19, 2024, 4:00 PM
7.79
-0.06 (-0.83%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Ocular Therapeutix Market Cap
Ocular Therapeutix has a market cap or net worth of $1.22 billion as of July 22, 2024. Its market cap has increased by 223.37% in one year.
Market Cap
1.22B
Enterprise Value
805.63M
1-Year Change
223.37%
Ranking
Category
Stock Price
$7.85
Market Cap Chart
Since July 25, 2014, Ocular Therapeutix's market cap has increased from $270.50M to $1.22B, an increase of 349.49%. That is a compound annual growth rate of 16.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.22B | 243.28% |
| Dec 29, 2023 | 354.20M | 63.68% |
| Dec 30, 2022 | 216.40M | -59.48% |
| Dec 31, 2021 | 534.00M | -63.87% |
| Dec 31, 2020 | 1.48B | 678.20% |
| Dec 31, 2019 | 189.90M | 16.08% |
| Dec 31, 2018 | 163.60M | 24.89% |
| Dec 29, 2017 | 131.00M | -37.08% |
| Dec 30, 2016 | 208.20M | -10.18% |
| Dec 31, 2015 | 231.80M | -53.78% |
| Dec 31, 2014 | 501.50M | 85.40% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ardelyx | 1.29B |
| Sana Biotechnology | 1.28B |
| Prothena Corporation | 1.27B |
| Omnicell | 1.26B |
| Establishment Labs Holdings | 1.25B |
| Xencor | 1.18B |
| AtriCure | 1.17B |
| Maravai LifeSciences Holdings | 1.15B |